Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Amortizatization of Intangibles: 2010-2015

Historic Amortizatization of Intangibles for Gyre Therapeutics (GYRE) over the last 4 years, with Jun 2015 value amounting to $63,000.

  • Gyre Therapeutics' Amortizatization of Intangibles fell 72.12% to $63,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $484,000, marking a year-over-year decrease of 41.62%. This contributed to the annual value of $775,000 for FY2014, which is 14.65% down from last year.
  • Gyre Therapeutics' Amortizatization of Intangibles amounted to $63,000 in Q2 2015, which was down 35.05% from $97,000 recorded in Q1 2015.
  • Gyre Therapeutics' Amortizatization of Intangibles' 5-year high stood at $335,000 during Q3 2011, with a 5-year trough of $63,000 in Q2 2015.
  • In the last 3 years, Gyre Therapeutics' Amortizatization of Intangibles had a median value of $203,500 in 2014 and averaged $184,300.
  • In the last 5 years, Gyre Therapeutics' Amortizatization of Intangibles soared by 125.00% in 2011 and then plummeted by 72.12% in 2015.
  • Gyre Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $270,000 in 2011, then fell by 23.33% to $207,000 in 2012, then grew by 10.14% to $228,000 in 2013, then crashed by 37.72% to $142,000 in 2014, then slumped by 72.12% to $63,000 in 2015.
  • Its Amortizatization of Intangibles was $63,000 in Q2 2015, compared to $97,000 in Q1 2015 and $142,000 in Q4 2014.